DUBLIN--(BUSINESS WIRE)--
ICON
plc, (NASDAQ: ICLR), a global provider of outsourced
development services to the pharmaceutical, biotechnology and medical
device industries, today announced the appointment of Professor William
Hall as a non-executive director.
A renowned expert in infectious diseases and virology, Professor Hall is
Chair of Medical Microbiology and Director of the Centre for Research in
Infectious Diseases at University College Dublin's (UCD) School of
Medicine and Medical Science. He is also a director of UCD's National
Virus Reference Laboratory and is a consultant microbiologist at St.
Vincent's University Hospital Dublin. Professor Hall also serves as a
consultant to the Minister of Heath and Children in the Republic of
Ireland, providing input on a number of topics including influenza
pandemic preparedness and bioterrorism.
Prior to his tenure at UCD, Professor Hall was Professor and Head of the
Laboratory of Medical Virology, Senior Physician and Director of the
Clinical Research Centre at the Rockefeller University in New York. He
has also served as an Assistant and Associate Professor of Medicine at
Cornell University.
Professor Hall is a board member of The Atlantic Philanthropies and is a
co-founder of the Global Virus Network.
"We are delighted to welcome Professor Hall to the ICON Board,"
commented Chairman, Mr. Thomas Lynch. "His knowledge and expertise in
virology and infectious diseases, coupled with his international
research collaborations in these fields will complement the strengths
and talents of our existing board members."
The information contained in this release is as of 21st
February 2013. The statements made in this press release may contain
forward-looking statements that involve a number of risks and
uncertainties. A description of risks and uncertainties relating to ICON
and its business can be found in ICON's
Annual Report for the fiscal year ended December 31, 2011 and in the
forms filed with the US
Securities and Exchange Commission, including the Forms 20-F, F-1,
S-8 and F-3. ICON disclaims any intent or obligation to update these
forward-looking statements.
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries. The
company specialises in the strategic development, management and
analysis of programs that support clinical development - from compound
selection to Phase I-IV clinical studies. With headquarters in Dublin,
Ireland, ICON currently, operates from 79 locations in 37 countries and
has approximately 10,045 employees. Further information is available at www.iconplc.com.
Source: ICON plc
ICON/ICLR-F
ICON plc
Investor Relations 1-888-381-7923
or
Brendan
Brennan Chief Financial Officer
+ 353 —1-291-2000
or
Sam
Farthing VP Investor Relations
+ 353 —1-291-2000
or
Simon
Holmes EVP Investor Relations and Corporate Development
+ 353
—1-291-2000
Source: ICON plc
News Provided by Acquire Media
